New treatment reduces pathogenic IgG while preserving B‑cell function

Phase 2 study to assess muscarinic M1 agonist in Alzheimer’s cognition

sBLA covers dMMR/MSI‑H stage II–III rectal cancer

Anthropic, twist and Adaptyv validate 1,320 binders across 15 targets

Designation supports rapid development of pan‑RAS molecular glue

New device classification created for precision optical filter

Autoinjector offers at‑home dosing from start of treatment

European ruling supports development in rare endocrine disorders

Early results show safety, CSF penetration and PK clarity

First participant enrolled in EquilibriX S study